140 related articles for article (PubMed ID: 23936312)
1. WT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin D1 and p-pRb in vitro and in vivo.
Xu C; Wu C; Xia Y; Zhong Z; Liu X; Xu J; Cui F; Chen B; Røe OD; Li A; Chen Y
PLoS One; 2013; 8(8):e68837. PubMed ID: 23936312
[TBL] [Abstract][Full Text] [Related]
2. WT1 promotes invasion of NSCLC via suppression of CDH1.
Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
[TBL] [Abstract][Full Text] [Related]
3. Wilms' tumor 1 enhances Cisplatin-resistance of advanced NSCLC.
Wu C; Wang Y; Xia Y; He S; Wang Z; Chen Y; Wu C; Shu Y; Jiang J
FEBS Lett; 2014 Dec; 588(24):4566-72. PubMed ID: 25447528
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
5. LncRNA WT1-AS over-expression inhibits non-small cell lung cancer cell stemness by down-regulating TGF-β1.
Jiang X; Wang J; Fang L
BMC Pulm Med; 2020 Apr; 20(1):113. PubMed ID: 32349718
[TBL] [Abstract][Full Text] [Related]
6. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of PAX6 by shRNA inhibits proliferation and cell cycle progression of human non-small cell lung cancer cell lines.
Zhao X; Yue W; Zhang L; Ma L; Jia W; Qian Z; Zhang C; Wang Y
PLoS One; 2014; 9(1):e85738. PubMed ID: 24454925
[TBL] [Abstract][Full Text] [Related]
8. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.
Cao W; Ribeiro Rde O; Liu D; Saintigny P; Xia R; Xue Y; Lin R; Mao L; Ren H
PLoS One; 2012; 7(12):e52984. PubMed ID: 23300840
[TBL] [Abstract][Full Text] [Related]
9. p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.
Vonlanthen S; Heighway J; Kappeler A; Altermatt HJ; Borner MM; Betticher DC
Int J Oncol; 2000 May; 16(5):951-7. PubMed ID: 10762631
[TBL] [Abstract][Full Text] [Related]
10. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
11. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
[TBL] [Abstract][Full Text] [Related]
12. The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway.
Tian XP; Jin XH; Li M; Huang WJ; Xie D; Zhang JX
Mol Cancer; 2017 Apr; 16(1):74. PubMed ID: 28372542
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880
[TBL] [Abstract][Full Text] [Related]
14. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
15. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.
Zhou JX; Niehans GA; Shar A; Rubins JB; Frizelle SP; Kratzke RA
Lung Cancer; 2001 Apr; 32(1):27-38. PubMed ID: 11282426
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
You W; Chen B; Liu X; Xue S; Qin H; Jiang H
Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
19. Homeobox Transcription Factor NKX2-1 Promotes
Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.
Amin KM; Litzky LA; Smythe WR; Mooney AM; Morris JM; Mews DJ; Pass HI; Kari C; Rodeck U; Rauscher FJ
Am J Pathol; 1995 Feb; 146(2):344-56. PubMed ID: 7856747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
